Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Advances of molecular subtype and targeted therapy of lung cancer].

Zhongguo fei ai za zhi = Chinese journal of lung cancer - 1 Sept 2012

Shao Lan, Song Zhengbo, Zhang Yiping, Su Dan

Abstract excerpt

The discovery of multiple molecular mechanisms underlying the development, progression, and prognosis of lung cancer, has created new opportunities for targeted therapy. Each subtype is associated with molecular tests that define the subtype and drugs that may have potential therapeutic effect on lung cancer. In 2004, mutations in the epidermal growth factor receptor (epidermal growth factor receptor, EGFR) gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to ErbB Receptors
Share to Lung Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins c-met

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 22989458
DOI: 10.3779/j.issn.1009-3419.2012.09.07
PMCID: PMC5999864

Genes

EGFR
ALK
EML4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Advances of molecular subtype and targeted therapy of lung cancer].PMID 22989458Read ↗

[Research progress in non-small cell lung cancer with concomitant EML4-ALK fusion gene and EGFR gene mutation].Semantic proximity Read ↗

Lung cancer and metastasis: new opportunities and challenges.Semantic proximity Read ↗

Molecular oncology of lung cancer.Semantic proximity Read ↗

[Molecular pathology of pulmonary carcinomas].Semantic proximity Read ↗

Lung Cancer Genomics in the Era of Accelerated Targeted Drug Development.Semantic proximity Read ↗

Lung Cancer—Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature)Semantic proximity Read ↗

Pulmonary adenocarcinoma: a renewed entity in 2011.Semantic proximity Read ↗

Genomic classification of lung cancer: toward a personalized treatment.Semantic proximity Read ↗

[Biomarkers and targeted therapies in non-small cell lung cancer: present and future treatments].Semantic proximity Read ↗

[Correlation between the new lung adenocarcinoma classification and epidermal growth factor receptor mutation].Semantic proximity Read ↗

Target Therapy in Lung Cancer.Semantic proximity Read ↗

Personalized targeted therapy for lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.